Reset Therapeutics is focused on harnessing the power of the body's internal molecular clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications. Molecular clocks are the foundation of the body's circadian system, which synchronizes many biological processes with cycles of light, activity and nutrient status. Reset has leveraged its leadership in molecular clocks to build a robust technology platform for discovering small molecule therapies that modulate circadian activity. The platform is a powerful engine for identifying components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular disease, thus far delivering development programs for narcolepsy and diabetes